XiangRui Li Selected Research

ADP-Ribosylation Factor 1

7/2022

Hepatocellular carcinoma-associated antigen 59 and ADP-ribosylation factor 1 with poly (lactic-co-glycolic acid): A promising candidate as nanovaccine against haemonchosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

XiangRui Li Research Topics

Disease

8	Infections 01/2022 - 01/2012
4	Coccidiosis 12/2022 - 06/2020
4	Toxoplasmosis 01/2022 - 04/2015
3	Hepatocellular Carcinoma (Hepatoma) 07/2022 - 03/2019
3	Body Weight (Weight, Body) 11/2016 - 01/2014
1	Parasitic Diseases (Parasitic Disease) 06/2019
1	Nematode Infections 06/2019
1	Anemia 09/2017

Drug/Important Bio-Agent (IBA)

7	VaccinesIBA 12/2022 - 01/2012
5	AntigensIBA 07/2022 - 03/2019
3	NanovaccinesIBA 07/2022 - 04/2021
3	DNA VaccinesIBA 01/2022 - 01/2012
3	Recombinant ProteinsIBA 11/2016 - 01/2014
2	Polylactic Acid-Polyglycolic Acid CopolymerIBA 07/2022 - 04/2021
2	Interleukin-2 (IL2)IBA 01/2019 - 01/2012
2	A-Form DNA (A-DNA)IBA 10/2015 - 01/2012
1	ADP-Ribosylation Factor 1IBA 07/2022
1	EpitopesIBA 04/2022
1	Destrin (Actin Depolymerizing Factor)IBA 01/2022
1	ribosomal phosphoprotein P2IBA 01/2022
1	ChitosanIBA 01/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 05/2021
1	Interleukin-4 (Interleukin 4)IBA 06/2019
1	CytokinesIBA 06/2019
1	Blood Proteins (Serum Proteins)IBA 09/2017
1	Peptide Elongation Factors (Elongation Factor)IBA 10/2015
1	Proteins (Proteins, Gene)FDA Link 08/2015

Therapy/Procedure

1	Nanospheres 04/2022
1	Immunomodulation 11/2018